Haemonetics Corp
HAE79.910USD
-0.100-0.12%
Market hours （ET）Quotes delayed by 15 min
3.74BMarket Cap
23.28P/E TTM
More Details of Haemonetics Corp Company
Haemonetics Corporation is a global healthcare company. The Company is engaged in providing a suite of medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. The Company’s technology addresses various medical markets, including blood and plasma component collection, the surgical suite, and hospital transfusion services. The Company’s Plasma segment includes plasma collection devices and disposables, donor management software and supporting software solutions sold to plasma customers. Its Blood Center segment manufactures and provides customers with its full line of apheresis solutions for automated blood collection. The Company’s Hospital segment consists of Interventional Technologies, which includes Vascular Closure, Sensor Guided Technologies and Esophageal Protection products, and Blood Management Technologies, which includes Hemostasis Management, Cell Salvage and Transfusion Management products.
Haemonetics Corp Info
Ticker SymbolHAE
Company nameHaemonetics Corp
IPO dateOct 17, 1979
CEOSimon (Christopher A)
Number of employees3023
Security typeOrdinary Share
Fiscal year-endOct 17
Address125 Summer Street
CityBOSTON
Stock exchangeNASDAQ OMX NASDAQ Basic NYSE
CountryUnited States of America
Postal code02110
Phone17818487100
Websitehttps://www.haemonetics.com
Ticker SymbolHAE
IPO dateOct 17, 1979
CEOSimon (Christopher A)
Company Executives of Haemonetics Corp
Name
Name/Position
Position
Shareholding
Change
Ms. Laurie A. Miller
Ms. Laurie A. Miller
Chief Human Resources Officer, Senior Vice President
Chief Human Resources Officer, Senior Vice President
28.01K
-0.84%
Mr. Charles J. Dockendorff, CPA
Mr. Charles J. Dockendorff, CPA
Independent Director
Independent Director
25.04K
+12.05%
Mr. Robert E. Abernathy
Mr. Robert E. Abernathy
Independent Director
Independent Director
24.98K
+12.08%
Dr. Mark W. Kroll, Ph.D.
Dr. Mark W. Kroll, Ph.D.
Independent Director
Independent Director
24.76K
+5.99%
Ms. Michelle L. Basil, J.D.
Ms. Michelle L. Basil, J.D.
Executive Vice President, General Counsel
Executive Vice President, General Counsel
19.69K
+2.11%
Ms. Ellen M. Zane
Ms. Ellen M. Zane
Independent Chairman of the Board
Independent Chairman of the Board
19.37K
+16.15%
Mr. Michael J. Coyle
Mr. Michael J. Coyle
Independent Director
Independent Director
15.39K
+21.20%
Ms. Diane M. Bryant
Ms. Diane M. Bryant
Independent Director
Independent Director
7.13K
+60.75%
Mr. Roy Galvin
Mr. Roy Galvin
Executive Vice President, Chief Commercial Officer
Executive Vice President, Chief Commercial Officer
3.24K
-4.28%
Mr. Frank W. Chan
Mr. Frank W. Chan
Chief Operating Officer, Executive Vice President
Chief Operating Officer, Executive Vice President
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Ms. Laurie A. Miller
Ms. Laurie A. Miller
Chief Human Resources Officer, Senior Vice President
Chief Human Resources Officer, Senior Vice President
28.01K
-0.84%
Mr. Charles J. Dockendorff, CPA
Mr. Charles J. Dockendorff, CPA
Independent Director
Independent Director
25.04K
+12.05%
Mr. Robert E. Abernathy
Mr. Robert E. Abernathy
Independent Director
Independent Director
24.98K
+12.08%
Dr. Mark W. Kroll, Ph.D.
Dr. Mark W. Kroll, Ph.D.
Independent Director
Independent Director
24.76K
+5.99%
Ms. Michelle L. Basil, J.D.
Ms. Michelle L. Basil, J.D.
Executive Vice President, General Counsel
Executive Vice President, General Counsel
19.69K
+2.11%
Ms. Ellen M. Zane
Ms. Ellen M. Zane
Independent Chairman of the Board
Independent Chairman of the Board
19.37K
+16.15%
Revenue Breakdown
Currency: USDUpdated: Mon, Oct 6
Currency: USDUpdated: Mon, Oct 6
FY2026Q1
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2021
FY2020
FY2019
Relevant data have not been disclosed by the company yet.
By RegionUSD
Name
Revenue
Proportion
United States
242.40M
75.42%
Europe
40.88M
12.72%
Asia
21.65M
6.74%
Japan
13.65M
4.25%
other
2.81M
0.87%
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Sun, Nov 16
Updated: Sun, Nov 16
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
11.33%
The Vanguard Group, Inc.
10.30%
Neuberger Berman, LLC
7.84%
AQR Capital Management, LLC
4.55%
State Street Investment Management (US)
3.85%
Other
62.13%
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
11.33%
The Vanguard Group, Inc.
10.30%
Neuberger Berman, LLC
7.84%
AQR Capital Management, LLC
4.55%
State Street Investment Management (US)
3.85%
Other
62.13%
Shareholder Types
Shareholders
Proportion
Investment Advisor
50.18%
Investment Advisor/Hedge Fund
45.79%
Hedge Fund
9.57%
Research Firm
4.36%
Bank and Trust
1.39%
Individual Investor
1.23%
Sovereign Wealth Fund
1.13%
Pension Fund
1.03%
Family Office
0.11%
Institutional Shareholding
Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
697
54.60M
116.65%
-5.18M
2025Q2
700
57.31M
118.95%
-4.19M
2025Q1
723
57.94M
120.44%
-3.07M
2024Q4
701
58.48M
116.40%
-1.44M
2024Q3
689
57.60M
112.60%
-1.51M
2024Q2
668
57.60M
113.31%
+3.07M
2024Q1
655
52.49M
103.35%
-1.26M
2023Q4
647
51.85M
102.19%
-3.31M
2023Q3
657
52.00M
102.54%
-4.11M
2023Q2
656
51.75M
102.38%
-4.68M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
BlackRock Institutional Trust Company, N.A.
5.57M
11.56%
-96.61K
-1.71%
Jun 30, 2025
The Vanguard Group, Inc.
4.94M
10.26%
-145.60K
-2.86%
Jun 30, 2025
Neuberger Berman, LLC
4.28M
8.88%
-70.91K
-1.63%
Jun 30, 2025
State Street Investment Management (US)
1.88M
3.91%
-34.03K
-1.77%
Jun 30, 2025
River Road Asset Management, LLC
1.66M
3.44%
+260.62K
+18.68%
Jun 30, 2025
UBS Financial Services, Inc.
869.79K
1.81%
+453.69K
+109.04%
Jun 30, 2025
Geode Capital Management, L.L.C.
1.24M
2.58%
+23.26K
+1.90%
Jun 30, 2025
Dimensional Fund Advisors, L.P.
1.07M
2.23%
+9.05K
+0.85%
Jun 30, 2025
Allspring Global Investments, LLC
949.48K
1.97%
-16.68K
-1.73%
Jun 30, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
Neuberger Berman Small-Mid Cap ETF
2.34%
State Street SPDR S&P Health Care Equipment ETF
1.66%
Harbor Human Capital Factor US Small Cap ETF
1.51%
Lattice Hartford Multifactor Small Cap ETF
0.54%
Inspire Small/Mid Cap ESG ETF
0.34%
WisdomTree US SmallCap Quality Growth Fund
0.3%
Principal U.S. Small-Cap ETF
0.28%
VictoryShares US Small Mid Cap Value Momentum ETF
0.26%
Royce Quant Small-Cap Quality Value ETF
0.24%
Amplify Etho Climate Leadership U.S. ETF
0.22%
View more
Neuberger Berman Small-Mid Cap ETF
Proportion2.34%
State Street SPDR S&P Health Care Equipment ETF
Proportion1.66%
Harbor Human Capital Factor US Small Cap ETF
Proportion1.51%
Lattice Hartford Multifactor Small Cap ETF
Proportion0.54%
Inspire Small/Mid Cap ESG ETF
Proportion0.34%
WisdomTree US SmallCap Quality Growth Fund
Proportion0.3%
Principal U.S. Small-Cap ETF
Proportion0.28%
VictoryShares US Small Mid Cap Value Momentum ETF
Proportion0.26%
Royce Quant Small-Cap Quality Value ETF
Proportion0.24%
Amplify Etho Climate Leadership U.S. ETF
Proportion0.22%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
FAQs
Who are the top five shareholders of Haemonetics Corp?
The top five shareholders of Haemonetics Corp are:
BlackRock Institutional Trust Company, N.A. holds 5.57M shares, accounting for 11.56% of the total shares.
The Vanguard Group, Inc. holds 4.94M shares, accounting for 10.26% of the total shares.
Neuberger Berman, LLC holds 4.28M shares, accounting for 8.88% of the total shares.
State Street Investment Management (US) holds 1.88M shares, accounting for 3.91% of the total shares.
River Road Asset Management, LLC holds 1.66M shares, accounting for 3.44% of the total shares.
BlackRock Institutional Trust Company, N.A. holds 5.57M shares, accounting for 11.56% of the total shares.
The Vanguard Group, Inc. holds 4.94M shares, accounting for 10.26% of the total shares.
Neuberger Berman, LLC holds 4.28M shares, accounting for 8.88% of the total shares.
State Street Investment Management (US) holds 1.88M shares, accounting for 3.91% of the total shares.
River Road Asset Management, LLC holds 1.66M shares, accounting for 3.44% of the total shares.
What are the top three shareholder types of Haemonetics Corp?
The top three shareholder types of Haemonetics Corp are:
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
Neuberger Berman, LLC
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
Neuberger Berman, LLC
How many institutions hold shares of Haemonetics Corp (HAE)?
As of 2025Q3, 697 institutions hold shares of Haemonetics Corp, with a combined market value of approximately 54.60M, accounting for 116.65% of the total shares. Compared to 2025Q2, institutional shareholding has increased by -2.30%.
What is the biggest source of revenue for Haemonetics Corp?
In FY2026Q1, the -- business generated the highest revenue for Haemonetics Corp, amounting to -- and accounting for --% of total revenue.
